Follow

In the face of rapidly rising numbers of people with Alzheimer's disease and other forms of dementia, new treatments and prevention approaches are critically needed. Dr. Ashok Shetty and his team are developing new therapies, including stem cell-derived vesicle therapies, to slow brain aging and fight Alzheimer's disease by targeting brain inflammation. I enjoyed speaking with him about his latest work, his scientific career, some of his biggest challenges, advice for aspiring scientists, and more in our latest podcast episode.

peoplebehindthescience.com/dr-

Thank you to Innovative Research for providing support for this podcast episode!

@PhDMarie

my 1st rxn was this sounds like pseudoscience, but after reading this

pubmed.ncbi.nlm.nih.gov/402516

dunno
it doesn't sound that good to me, but I'm not an expert

I didn't bother to look at the PNAS papers

medicine.tamu.edu/faculty-list

@failedLyndonLaRouchite I think the research in this area is still very early, but it is exciting to see that this approach could represent a non-invasive way to deliver targeted treatments to the brain to potentially slow (likely not stop) brain aging.

Sign in to participate in the conversation
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.